Serina Therapeutics Inc (SER) — Cash Flow Quality Index
Serina Therapeutics Inc (SER) has a Cash Flow Quality Index of -2.14x as of September 2024. Operating cash flow of $-2.96 Million is below net income of $1.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Serina Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Serina Therapeutics Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Serina Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SER cash flow conversion.
Annual Cash Flow Quality Index for Serina Therapeutics Inc (2023–2023)
Year-by-year earnings quality comparison for Serina Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.47x | $-2.48 Million | $5.27 Million | — |